Name：Center of Postmarketing Safety Evaluation PUHSC
Drug safety policy and management, evidence-based decision making, pharmacoepidemiology, medicinal Administration, drug safety evaluation
Provide consultations for central and local governments, including Ministry of Health, SFDA and NDRC.
Carry out training program specially designed for supervisors, enterprise staff and researchers.
Methodology Study: Carry out methodology researches of pharmaco-epidemiology, for instance database mining, safety signals detection and analysis and so on.
Make methodology guideline of Post-Marketing Study to provide the basis for government’s policy-making.
Conduct safety evaluation of innovative drugs, essential drugs, Chinese medicine injections and high-risk drugs on commission of state and enterprise.
Director: Siyan Zhan
Contact: Feng Sun
Address: Room 519, School of Public Health Building Peking University Health Science Center, 38 Xue Yuan Road, Beijing, China. Post Code: 100191